FDA Approved: GANCICLOVIR — Supplemental Application (Pharmascience Inc.)

View source ↗

Summary

FDA approved Pharmascience Inc.'s supplemental application for ganciclovir sodium, allowing its continued marketing as a generic antiviral.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Cytomegalovirus Retinitis

Drugs mentioned

• GANCICLOVIR SODIUM (GANCICLOVIR SODIUM)

Snippet

SUPPL AP for GANCICLOVIR (GANCICLOVIR SODIUM)